| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Iodine Radioisotopes | 77 | 2012 | 1030 | 6.080 |
Why?
|
| Idoxuridine | 33 | 2012 | 123 | 3.960 |
Why?
|
| Electrons | 23 | 2012 | 268 | 2.510 |
Why?
|
| Radioisotopes | 20 | 2011 | 499 | 2.360 |
Why?
|
| Prodrugs | 8 | 2012 | 268 | 2.180 |
Why?
|
| Bystander Effect | 5 | 2012 | 81 | 1.600 |
Why?
|
| DNA | 30 | 2012 | 7289 | 1.520 |
Why?
|
| DNA, Superhelical | 6 | 2012 | 50 | 1.460 |
Why?
|
| Radiopharmaceuticals | 21 | 2010 | 2658 | 1.430 |
Why?
|
| Hydroxyl Radical | 9 | 2008 | 78 | 1.250 |
Why?
|
| Quinazolinones | 6 | 2012 | 221 | 1.250 |
Why?
|
| DNA Damage | 24 | 2010 | 2423 | 1.190 |
Why?
|
| Gamma Rays | 14 | 2012 | 320 | 1.080 |
Why?
|
| Cell Physiological Phenomena | 4 | 2010 | 154 | 1.080 |
Why?
|
| Isotope Labeling | 17 | 2012 | 414 | 1.070 |
Why?
|
| Coumarins | 8 | 2008 | 119 | 1.030 |
Why?
|
| Plasmids | 11 | 2011 | 2305 | 0.990 |
Why?
|
| Alkaline Phosphatase | 5 | 2011 | 865 | 0.820 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2012 | 589 | 0.780 |
Why?
|
| Cell Survival | 25 | 2007 | 5872 | 0.740 |
Why?
|
| DNA Breaks, Single-Stranded | 2 | 2011 | 23 | 0.730 |
Why?
|
| Fluorescent Dyes | 8 | 2012 | 1915 | 0.730 |
Why?
|
| Benzimidazoles | 7 | 2008 | 848 | 0.730 |
Why?
|
| Drug Delivery Systems | 8 | 2009 | 2217 | 0.710 |
Why?
|
| Radiobiology | 5 | 2008 | 85 | 0.680 |
Why?
|
| Dose-Response Relationship, Radiation | 14 | 2012 | 876 | 0.660 |
Why?
|
| Models, Molecular | 8 | 2012 | 5454 | 0.650 |
Why?
|
| Neoplasms | 24 | 2011 | 21596 | 0.650 |
Why?
|
| Dimethyl Sulfoxide | 9 | 2007 | 249 | 0.630 |
Why?
|
| Electrophoresis, Agar Gel | 4 | 2011 | 212 | 0.570 |
Why?
|
| Tissue Distribution | 20 | 2007 | 2335 | 0.550 |
Why?
|
| Microarray Analysis | 2 | 2009 | 766 | 0.530 |
Why?
|
| Neoplasms, Experimental | 7 | 2002 | 1274 | 0.500 |
Why?
|
| Cricetinae | 26 | 2007 | 2471 | 0.500 |
Why?
|
| Nucleic Acid Conformation | 7 | 2012 | 914 | 0.500 |
Why?
|
| Indium Radioisotopes | 14 | 2000 | 118 | 0.480 |
Why?
|
| Gliosarcoma | 4 | 1998 | 114 | 0.470 |
Why?
|
| Radiation Dosage | 16 | 2010 | 1927 | 0.460 |
Why?
|
| Ethidium | 3 | 2008 | 26 | 0.460 |
Why?
|
| Radiometry | 4 | 2008 | 800 | 0.450 |
Why?
|
| Radionuclide Imaging | 16 | 2008 | 2027 | 0.430 |
Why?
|
| Hydrolysis | 6 | 2012 | 682 | 0.410 |
Why?
|
| Antibodies, Monoclonal | 17 | 2007 | 9274 | 0.410 |
Why?
|
| Cricetulus | 17 | 2007 | 817 | 0.400 |
Why?
|
| Radioimmunodetection | 3 | 1996 | 46 | 0.400 |
Why?
|
| Meningitis | 3 | 2008 | 216 | 0.400 |
Why?
|
| DNA, Circular | 1 | 2011 | 96 | 0.390 |
Why?
|
| Octreotide | 2 | 2002 | 145 | 0.380 |
Why?
|
| Models, Biological | 7 | 2010 | 9581 | 0.380 |
Why?
|
| Sodium Iodide | 3 | 2008 | 13 | 0.370 |
Why?
|
| Radiotherapy | 3 | 2008 | 1525 | 0.360 |
Why?
|
| Animals | 104 | 2011 | 168561 | 0.360 |
Why?
|
| Spermidine | 1 | 2008 | 56 | 0.340 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 2 | 2000 | 112 | 0.340 |
Why?
|
| Technetium Tc 99m Sestamibi | 2 | 2000 | 176 | 0.340 |
Why?
|
| Biophysics | 2 | 2008 | 383 | 0.340 |
Why?
|
| Spermine | 1 | 2008 | 70 | 0.330 |
Why?
|
| Computational Biology | 2 | 2011 | 3518 | 0.320 |
Why?
|
| Methotrexate | 3 | 2008 | 1720 | 0.320 |
Why?
|
| Access to Information | 1 | 2011 | 320 | 0.310 |
Why?
|
| Cell Nucleus | 10 | 2012 | 2968 | 0.300 |
Why?
|
| Tumor Cells, Cultured | 9 | 2007 | 6313 | 0.300 |
Why?
|
| Antibodies, Neoplasm | 4 | 2007 | 286 | 0.300 |
Why?
|
| Mice, Nude | 12 | 2006 | 3689 | 0.300 |
Why?
|
| Paralysis | 3 | 2004 | 249 | 0.300 |
Why?
|
| Neoplasm Proteins | 3 | 2011 | 3691 | 0.290 |
Why?
|
| Polyamines | 1 | 2007 | 120 | 0.290 |
Why?
|
| Molecular Probes | 1 | 2008 | 316 | 0.290 |
Why?
|
| Pentetic Acid | 3 | 1994 | 213 | 0.290 |
Why?
|
| Isoenzymes | 1 | 2011 | 1725 | 0.290 |
Why?
|
| Databases, Genetic | 2 | 2011 | 1780 | 0.280 |
Why?
|
| Intercalating Agents | 5 | 1997 | 33 | 0.280 |
Why?
|
| PubMed | 1 | 2006 | 122 | 0.270 |
Why?
|
| Radiotherapy Dosage | 8 | 2008 | 2876 | 0.270 |
Why?
|
| Prostatic Neoplasms | 9 | 2023 | 11039 | 0.270 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2007 | 205 | 0.270 |
Why?
|
| Models, Chemical | 2 | 2005 | 626 | 0.270 |
Why?
|
| Oligonucleotides | 1 | 2008 | 572 | 0.260 |
Why?
|
| Autoradiography | 8 | 2007 | 749 | 0.260 |
Why?
|
| Extracellular Space | 1 | 2007 | 594 | 0.250 |
Why?
|
| Isoelectric Focusing | 2 | 1995 | 181 | 0.250 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 473 | 0.250 |
Why?
|
| Computer Simulation | 5 | 2012 | 6191 | 0.240 |
Why?
|
| Molecular Biology | 1 | 2008 | 595 | 0.240 |
Why?
|
| Neoplasm Transplantation | 8 | 2003 | 2085 | 0.240 |
Why?
|
| Free Radical Scavengers | 4 | 1999 | 217 | 0.240 |
Why?
|
| Lymphocytes | 1 | 2012 | 2614 | 0.240 |
Why?
|
| Databases, Protein | 1 | 2006 | 383 | 0.240 |
Why?
|
| Astatine | 2 | 1998 | 10 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2011 | 8425 | 0.230 |
Why?
|
| Immunoglobulin G | 12 | 2007 | 4554 | 0.230 |
Why?
|
| Biotin | 2 | 1996 | 253 | 0.220 |
Why?
|
| Serum Albumin | 3 | 1995 | 674 | 0.220 |
Why?
|
| Iodobenzenes | 2 | 1993 | 24 | 0.220 |
Why?
|
| Gene Targeting | 1 | 2006 | 880 | 0.220 |
Why?
|
| Sulfhydryl Compounds | 2 | 1993 | 296 | 0.200 |
Why?
|
| Mice | 42 | 2007 | 81045 | 0.200 |
Why?
|
| Cell Line, Tumor | 8 | 2012 | 16665 | 0.200 |
Why?
|
| Receptors, Somatostatin | 1 | 2002 | 129 | 0.200 |
Why?
|
| Avidin | 3 | 1996 | 44 | 0.190 |
Why?
|
| Rhabdomyosarcoma | 2 | 2004 | 382 | 0.190 |
Why?
|
| Solutions | 5 | 2008 | 426 | 0.190 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 2 | 1990 | 66 | 0.190 |
Why?
|
| Drug Discovery | 1 | 2009 | 1057 | 0.190 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 824 | 0.190 |
Why?
|
| Linear Energy Transfer | 2 | 2005 | 154 | 0.180 |
Why?
|
| CHO Cells | 2 | 2007 | 1407 | 0.180 |
Why?
|
| Gangliosides | 2 | 1991 | 140 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 2633 | 0.180 |
Why?
|
| Carcinoma | 3 | 2008 | 2374 | 0.180 |
Why?
|
| Radiation-Protective Agents | 1 | 2000 | 89 | 0.180 |
Why?
|
| Solubility | 3 | 2007 | 1083 | 0.170 |
Why?
|
| Apoptosis | 2 | 2006 | 9715 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2007 | 1574 | 0.170 |
Why?
|
| Cell Line | 22 | 2002 | 15994 | 0.170 |
Why?
|
| Ovarian Neoplasms | 9 | 2008 | 4823 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2008 | 692 | 0.160 |
Why?
|
| Rats, Inbred F344 | 6 | 1998 | 862 | 0.160 |
Why?
|
| Rats | 19 | 2006 | 24265 | 0.160 |
Why?
|
| Rhodamines | 4 | 1998 | 183 | 0.160 |
Why?
|
| Adenocarcinoma | 6 | 2006 | 6347 | 0.160 |
Why?
|
| Antibodies | 5 | 1995 | 2459 | 0.160 |
Why?
|
| Antigens, Surface | 4 | 1991 | 1663 | 0.160 |
Why?
|
| Radioimmunotherapy | 2 | 1995 | 79 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2012 | 10472 | 0.160 |
Why?
|
| Injections, Spinal | 4 | 2008 | 303 | 0.160 |
Why?
|
| Half-Life | 4 | 2005 | 658 | 0.160 |
Why?
|
| DNA, Single-Stranded | 1 | 1999 | 353 | 0.150 |
Why?
|
| Acridines | 3 | 1997 | 19 | 0.150 |
Why?
|
| Hydroxides | 2 | 1998 | 47 | 0.150 |
Why?
|
| Genome, Human | 1 | 2011 | 4420 | 0.150 |
Why?
|
| Meningeal Neoplasms | 3 | 2008 | 1241 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1434 | 0.150 |
Why?
|
| Fibroblasts | 7 | 2001 | 4143 | 0.150 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 759 | 0.150 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2004 | 640 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 6 | 2007 | 2699 | 0.150 |
Why?
|
| Complement System Proteins | 5 | 1979 | 795 | 0.150 |
Why?
|
| Histones | 4 | 1996 | 2597 | 0.150 |
Why?
|
| Binding Sites | 4 | 2012 | 6115 | 0.150 |
Why?
|
| Iodine Compounds | 1 | 1996 | 30 | 0.150 |
Why?
|
| Humans | 72 | 2023 | 742088 | 0.140 |
Why?
|
| Bacterial Proteins | 3 | 2002 | 3843 | 0.140 |
Why?
|
| Carbon Radioisotopes | 1 | 1998 | 592 | 0.140 |
Why?
|
| Colonic Neoplasms | 3 | 2008 | 2542 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1224 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 3507 | 0.140 |
Why?
|
| Kinetics | 7 | 2011 | 6474 | 0.140 |
Why?
|
| Oxyquinoline | 2 | 1987 | 15 | 0.140 |
Why?
|
| Drug Design | 3 | 2007 | 1078 | 0.140 |
Why?
|
| Hydroxyquinolines | 2 | 1987 | 19 | 0.140 |
Why?
|
| Polylysine | 6 | 1997 | 133 | 0.140 |
Why?
|
| Proflavine | 3 | 1990 | 7 | 0.140 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9410 | 0.140 |
Why?
|
| Brain Neoplasms | 7 | 2008 | 8829 | 0.140 |
Why?
|
| Immunoglobulins | 3 | 1993 | 880 | 0.140 |
Why?
|
| Copper | 2 | 1996 | 366 | 0.140 |
Why?
|
| Radiation Protection | 4 | 1992 | 419 | 0.130 |
Why?
|
| Insulinoma | 3 | 1991 | 124 | 0.130 |
Why?
|
| Quinazolines | 1 | 2002 | 1355 | 0.130 |
Why?
|
| Immunotoxins | 1 | 1995 | 179 | 0.130 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1996 | 224 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 1996 | 2229 | 0.130 |
Why?
|
| Bleomycin | 1 | 1996 | 499 | 0.120 |
Why?
|
| Radiation Tolerance | 3 | 2006 | 484 | 0.120 |
Why?
|
| Crystallography, X-Ray | 2 | 2011 | 2014 | 0.120 |
Why?
|
| Organometallic Compounds | 3 | 1991 | 665 | 0.120 |
Why?
|
| Neuroendocrine Tumors | 1 | 2000 | 594 | 0.120 |
Why?
|
| Cells, Cultured | 12 | 2007 | 19223 | 0.120 |
Why?
|
| Echinococcus | 4 | 1977 | 16 | 0.120 |
Why?
|
| Echinococcosis | 4 | 1977 | 30 | 0.120 |
Why?
|
| Leucovorin | 1 | 1996 | 624 | 0.120 |
Why?
|
| Prostate-Specific Antigen | 1 | 2023 | 2458 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2008 | 2552 | 0.120 |
Why?
|
| Binding Sites, Antibody | 2 | 1991 | 349 | 0.120 |
Why?
|
| Rhodamine 123 | 3 | 1989 | 38 | 0.120 |
Why?
|
| Antibody Specificity | 3 | 1994 | 1094 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2011 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3770 | 0.110 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 3 | 2008 | 134 | 0.110 |
Why?
|
| Rabbits | 10 | 1995 | 4886 | 0.110 |
Why?
|
| Spectrometry, Fluorescence | 4 | 1996 | 689 | 0.110 |
Why?
|
| Fluorescence | 5 | 2002 | 751 | 0.110 |
Why?
|
| Xanthenes | 2 | 1989 | 73 | 0.110 |
Why?
|
| DNA Fragmentation | 2 | 2006 | 242 | 0.110 |
Why?
|
| Caffeine | 1 | 1997 | 699 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2012 | 68 | 0.110 |
Why?
|
| Radioimmunoassay | 2 | 1994 | 918 | 0.110 |
Why?
|
| Interleukin-1alpha | 1 | 2012 | 84 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 149 | 0.100 |
Why?
|
| Maleimides | 1 | 1992 | 112 | 0.100 |
Why?
|
| Floxuridine | 1 | 1991 | 47 | 0.100 |
Why?
|
| Boron Compounds | 1 | 1993 | 178 | 0.100 |
Why?
|
| Focal Infection | 1 | 1991 | 9 | 0.100 |
Why?
|
| Sulfotransferases | 1 | 2012 | 151 | 0.100 |
Why?
|
| Astrocytoma | 1 | 1996 | 789 | 0.100 |
Why?
|
| Endometritis | 1 | 1991 | 48 | 0.100 |
Why?
|
| Literature, Modern | 1 | 2011 | 31 | 0.100 |
Why?
|
| Static Electricity | 1 | 2011 | 267 | 0.100 |
Why?
|
| Radioactivity | 3 | 2008 | 63 | 0.100 |
Why?
|
| Fluorouracil | 1 | 1996 | 1615 | 0.100 |
Why?
|
| Chromatin | 2 | 2000 | 2917 | 0.100 |
Why?
|
| Indicators and Reagents | 3 | 1998 | 462 | 0.090 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1991 | 363 | 0.090 |
Why?
|
| Cells | 1 | 1992 | 168 | 0.090 |
Why?
|
| Radiation Effects | 1 | 1990 | 68 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 407 | 0.090 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 434 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 5 | 2012 | 5249 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 2940 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 1996 | 4249 | 0.090 |
Why?
|
| Catalysis | 1 | 2011 | 760 | 0.090 |
Why?
|
| Immunoglobulin M | 4 | 1988 | 1538 | 0.090 |
Why?
|
| Brachytherapy | 2 | 2012 | 1246 | 0.090 |
Why?
|
| Radiation Monitoring | 1 | 1990 | 97 | 0.090 |
Why?
|
| Antipyrine | 2 | 1999 | 40 | 0.090 |
Why?
|
| Ascites | 1 | 1991 | 344 | 0.090 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 218 | 0.090 |
Why?
|
| Iodobenzoates | 1 | 1989 | 10 | 0.090 |
Why?
|
| Thallium | 3 | 1984 | 101 | 0.090 |
Why?
|
| Ascitic Fluid | 2 | 1988 | 192 | 0.090 |
Why?
|
| Alpha Particles | 4 | 1993 | 26 | 0.090 |
Why?
|
| Liver | 3 | 2007 | 7470 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2011 | 699 | 0.080 |
Why?
|
| Schistosomiasis | 2 | 1979 | 62 | 0.080 |
Why?
|
| Transplantation, Heterologous | 4 | 2002 | 2382 | 0.080 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1996 | 798 | 0.080 |
Why?
|
| Titrimetry | 1 | 2008 | 36 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 4 | 1992 | 324 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2011 | 1676 | 0.080 |
Why?
|
| Gold | 1 | 2012 | 483 | 0.080 |
Why?
|
| Ligands | 2 | 2007 | 3293 | 0.080 |
Why?
|
| Exonucleases | 1 | 2008 | 47 | 0.080 |
Why?
|
| Culture Media | 2 | 2001 | 902 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2012 | 1341 | 0.080 |
Why?
|
| Technetium | 2 | 1989 | 334 | 0.080 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 403 | 0.080 |
Why?
|
| Solvents | 2 | 2007 | 302 | 0.080 |
Why?
|
| Organ Specificity | 2 | 2003 | 2003 | 0.080 |
Why?
|
| Radiochemistry | 1 | 2007 | 56 | 0.080 |
Why?
|
| Fluoresceins | 2 | 1998 | 234 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2011 | 3420 | 0.080 |
Why?
|
| Fibrosarcoma | 1 | 1989 | 348 | 0.080 |
Why?
|
| Iodine Isotopes | 1 | 2007 | 90 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2011 | 1802 | 0.080 |
Why?
|
| Aniline Compounds | 1 | 1992 | 983 | 0.070 |
Why?
|
| Acid Phosphatase | 1 | 2007 | 141 | 0.070 |
Why?
|
| Models, Theoretical | 4 | 2000 | 3584 | 0.070 |
Why?
|
| Thymine | 1 | 2007 | 68 | 0.070 |
Why?
|
| Abscess | 1 | 1991 | 607 | 0.070 |
Why?
|
| Adsorption | 3 | 1993 | 201 | 0.070 |
Why?
|
| Melanoma | 1 | 2005 | 5462 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 972 | 0.070 |
Why?
|
| Injections, Intralesional | 2 | 1998 | 276 | 0.070 |
Why?
|
| Water | 2 | 2008 | 1388 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2006 | 475 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 1996 | 6754 | 0.070 |
Why?
|
| Free Radicals | 3 | 1997 | 236 | 0.070 |
Why?
|
| Infusions, Intra-Arterial | 2 | 1996 | 231 | 0.070 |
Why?
|
| Microscopy, Atomic Force | 1 | 2006 | 248 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3133 | 0.070 |
Why?
|
| Data Mining | 1 | 2011 | 537 | 0.070 |
Why?
|
| Antigens | 2 | 1990 | 1462 | 0.070 |
Why?
|
| Whole-Body Counting | 1 | 2005 | 35 | 0.070 |
Why?
|
| Cattle | 5 | 1998 | 3923 | 0.070 |
Why?
|
| Chromium Radioisotopes | 1 | 1985 | 36 | 0.070 |
Why?
|
| Indium | 1 | 1985 | 46 | 0.070 |
Why?
|
| Lung | 8 | 2000 | 9826 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 964 | 0.070 |
Why?
|
| Isoelectric Point | 2 | 1995 | 80 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2006 | 594 | 0.060 |
Why?
|
| X-Rays | 2 | 2008 | 301 | 0.060 |
Why?
|
| Database Management Systems | 1 | 2006 | 270 | 0.060 |
Why?
|
| Male | 24 | 2023 | 349538 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3847 | 0.060 |
Why?
|
| Oxidation-Reduction | 4 | 2001 | 2187 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 13019 | 0.060 |
Why?
|
| Systems Integration | 1 | 2006 | 440 | 0.060 |
Why?
|
| Deoxy Sugars | 1 | 1983 | 20 | 0.060 |
Why?
|
| Streptavidin | 2 | 1996 | 81 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2006 | 759 | 0.060 |
Why?
|
| Radiography | 3 | 2010 | 7010 | 0.060 |
Why?
|
| Nucleosomes | 2 | 1998 | 493 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 35342 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2007 | 10943 | 0.060 |
Why?
|
| Fluorine | 1 | 1983 | 83 | 0.060 |
Why?
|
| Radionuclide Generators | 1 | 2003 | 12 | 0.060 |
Why?
|
| Spleen | 1 | 1990 | 2359 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2011 | 831 | 0.060 |
Why?
|
| Escherichia coli | 2 | 2011 | 4214 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2008 | 1184 | 0.060 |
Why?
|
| Liposomes | 1 | 1987 | 758 | 0.060 |
Why?
|
| Sulfonamides | 1 | 1993 | 1932 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 379 | 0.060 |
Why?
|
| Deoxyglucose | 1 | 1983 | 337 | 0.060 |
Why?
|
| Bromine | 1 | 1982 | 23 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1707 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2007 | 1539 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2002 | 2505 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 1997 | 731 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2002 | 117 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 7 | 2007 | 21821 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2008 | 933 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2002 | 3862 | 0.050 |
Why?
|
| Adenine | 1 | 2007 | 936 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2004 | 23387 | 0.050 |
Why?
|
| Sulfur Radioisotopes | 1 | 1980 | 116 | 0.050 |
Why?
|
| Methylcholanthrene | 1 | 2000 | 29 | 0.050 |
Why?
|
| DNA Repair | 2 | 2008 | 2042 | 0.050 |
Why?
|
| Succinimides | 3 | 1996 | 79 | 0.050 |
Why?
|
| Base Sequence | 1 | 2012 | 12797 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1969 | 0.050 |
Why?
|
| Photons | 1 | 2004 | 587 | 0.050 |
Why?
|
| Freezing | 1 | 2001 | 303 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2004 | 1791 | 0.050 |
Why?
|
| Methods | 2 | 1993 | 1128 | 0.050 |
Why?
|
| Cryoprotective Agents | 1 | 2001 | 111 | 0.050 |
Why?
|
| Drug Stability | 2 | 1992 | 290 | 0.050 |
Why?
|
| Rats, Nude | 1 | 2000 | 105 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 1998 | 5975 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2002 | 527 | 0.040 |
Why?
|
| Spinal Cord | 2 | 2000 | 1807 | 0.040 |
Why?
|
| Combined Modality Therapy | 4 | 2008 | 8621 | 0.040 |
Why?
|
| Lipid Peroxidation | 2 | 1998 | 270 | 0.040 |
Why?
|
| Lectins | 1 | 2002 | 514 | 0.040 |
Why?
|
| Watchful Waiting | 1 | 2023 | 491 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2008 | 4211 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 1811 | 0.040 |
Why?
|
| Cell Division | 2 | 2002 | 4564 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2000 | 327 | 0.040 |
Why?
|
| KB Cells | 1 | 1998 | 14 | 0.040 |
Why?
|
| Schistosoma haematobium | 1 | 1978 | 11 | 0.040 |
Why?
|
| Nitriles | 1 | 1984 | 952 | 0.040 |
Why?
|
| Protein Binding | 1 | 2011 | 9387 | 0.040 |
Why?
|
| S Phase | 1 | 2000 | 423 | 0.040 |
Why?
|
| Clone Cells | 1 | 2002 | 1692 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 1998 | 134 | 0.040 |
Why?
|
| Time Factors | 7 | 1998 | 40054 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2006 | 1035 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 1998 | 354 | 0.040 |
Why?
|
| Selenium | 1 | 1980 | 402 | 0.040 |
Why?
|
| Crohn Disease | 1 | 1991 | 2301 | 0.040 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1979 | 304 | 0.040 |
Why?
|
| Placenta | 1 | 2007 | 1694 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2001 | 774 | 0.040 |
Why?
|
| Ovum | 1 | 1978 | 189 | 0.040 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1999 | 358 | 0.040 |
Why?
|
| Eosinophils | 2 | 1979 | 953 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1758 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6171 | 0.040 |
Why?
|
| Immunotherapy | 4 | 1991 | 4414 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2000 | 395 | 0.040 |
Why?
|
| Peroxides | 1 | 1997 | 74 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1835 | 0.040 |
Why?
|
| Cell Communication | 1 | 2004 | 1619 | 0.040 |
Why?
|
| Methylnitrosourea | 1 | 1996 | 29 | 0.040 |
Why?
|
| Dimerization | 1 | 1998 | 893 | 0.030 |
Why?
|
| Administration, Intravesical | 1 | 1996 | 91 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1990 | 5019 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 1998 | 6382 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 1998 | 535 | 0.030 |
Why?
|
| Ferrous Compounds | 1 | 1996 | 42 | 0.030 |
Why?
|
| Energy Transfer | 2 | 1989 | 109 | 0.030 |
Why?
|
| Granuloma | 1 | 1978 | 315 | 0.030 |
Why?
|
| Female | 20 | 2008 | 379592 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6259 | 0.030 |
Why?
|
| Proteomics | 1 | 2009 | 3618 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 1996 | 730 | 0.030 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1998 | 285 | 0.030 |
Why?
|
| Antineoplastic Agents | 3 | 1998 | 13655 | 0.030 |
Why?
|
| Glioma | 1 | 1990 | 3388 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 1997 | 442 | 0.030 |
Why?
|
| Sepharose | 1 | 1995 | 108 | 0.030 |
Why?
|
| Endothelium, Vascular | 3 | 1993 | 4455 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 1996 | 242 | 0.030 |
Why?
|
| Chemical Phenomena | 2 | 1996 | 517 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1995 | 475 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 1994 | 132 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2002 | 5180 | 0.030 |
Why?
|
| Umbelliferones | 1 | 1993 | 12 | 0.030 |
Why?
|
| Cell Separation | 1 | 1980 | 1749 | 0.030 |
Why?
|
| Schistosoma mansoni | 3 | 1979 | 149 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1993 | 101 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2009 | 7716 | 0.030 |
Why?
|
| Cesium Radioisotopes | 1 | 1993 | 36 | 0.030 |
Why?
|
| Carcinogens | 1 | 1996 | 466 | 0.030 |
Why?
|
| Lysine | 1 | 1998 | 1008 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 1994 | 563 | 0.030 |
Why?
|
| Photochemistry | 1 | 1993 | 238 | 0.030 |
Why?
|
| Platinum | 1 | 1994 | 232 | 0.030 |
Why?
|
| Mercury | 1 | 1995 | 285 | 0.030 |
Why?
|
| Genomics | 1 | 2009 | 5692 | 0.030 |
Why?
|
| Area Under Curve | 1 | 1997 | 1653 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 1996 | 647 | 0.030 |
Why?
|
| Cobalt Radioisotopes | 1 | 1992 | 76 | 0.030 |
Why?
|
| Rubidium | 2 | 1983 | 133 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 4 | 1992 | 424 | 0.030 |
Why?
|
| Relative Biological Effectiveness | 2 | 1994 | 323 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2008 | 2964 | 0.030 |
Why?
|
| Biopsy | 1 | 2023 | 6756 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2000 | 1871 | 0.030 |
Why?
|
| Kupffer Cells | 1 | 1992 | 142 | 0.030 |
Why?
|
| Immunologic Capping | 1 | 1991 | 31 | 0.030 |
Why?
|
| Aorta, Abdominal | 2 | 1991 | 645 | 0.020 |
Why?
|
| Kidney | 1 | 2007 | 7167 | 0.020 |
Why?
|
| Cecal Diseases | 1 | 1991 | 51 | 0.020 |
Why?
|
| Goats | 1 | 1991 | 172 | 0.020 |
Why?
|
| Blood Platelets | 2 | 1992 | 2506 | 0.020 |
Why?
|
| Radiation | 1 | 1990 | 49 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 1990 | 1420 | 0.020 |
Why?
|
| Mitosis | 1 | 1996 | 1208 | 0.020 |
Why?
|
| Platelet Aggregation | 2 | 1991 | 800 | 0.020 |
Why?
|
| Immunoradiometric Assay | 1 | 1990 | 24 | 0.020 |
Why?
|
| Heart | 1 | 1984 | 4462 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 1990 | 547 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1989 | 70 | 0.020 |
Why?
|
| Chemistry | 1 | 1990 | 352 | 0.020 |
Why?
|
| Platelet Activation | 2 | 1991 | 671 | 0.020 |
Why?
|
| Doxorubicin | 1 | 1996 | 2215 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 11001 | 0.020 |
Why?
|
| Thallium Radioisotopes | 1 | 1989 | 139 | 0.020 |
Why?
|
| Protein Folding | 1 | 1993 | 843 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1996 | 1171 | 0.020 |
Why?
|
| Palliative Care | 1 | 2004 | 3478 | 0.020 |
Why?
|
| Selenium Radioisotopes | 1 | 1988 | 13 | 0.020 |
Why?
|
| Selenomethionine | 1 | 1988 | 16 | 0.020 |
Why?
|
| Immune Sera | 2 | 1979 | 641 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2008 | 20774 | 0.020 |
Why?
|
| Antibody Formation | 2 | 1992 | 1402 | 0.020 |
Why?
|
| Cysteine | 1 | 1993 | 873 | 0.020 |
Why?
|
| Technology, Radiologic | 1 | 1989 | 163 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 1996 | 5062 | 0.020 |
Why?
|
| Cisplatin | 1 | 1994 | 1637 | 0.020 |
Why?
|
| Iron | 1 | 1996 | 1773 | 0.020 |
Why?
|
| Embolism | 1 | 1991 | 409 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1992 | 546 | 0.020 |
Why?
|
| Microspheres | 1 | 1990 | 777 | 0.020 |
Why?
|
| Thymidine | 1 | 1987 | 309 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2004 | 62966 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1801 | 0.020 |
Why?
|
| Beta Particles | 1 | 1987 | 50 | 0.020 |
Why?
|
| Fluorometry | 2 | 1997 | 106 | 0.020 |
Why?
|
| Middle Aged | 8 | 2021 | 213127 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 15530 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14720 | 0.020 |
Why?
|
| Radiation Genetics | 1 | 1986 | 16 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 3127 | 0.020 |
Why?
|
| Endocytosis | 1 | 1990 | 983 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2023 | 23320 | 0.020 |
Why?
|
| Angiography | 1 | 1990 | 1636 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 18006 | 0.020 |
Why?
|
| Lysosomes | 1 | 1990 | 893 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1986 | 347 | 0.020 |
Why?
|
| Potassium Radioisotopes | 1 | 1983 | 12 | 0.020 |
Why?
|
| Isoantibodies | 1 | 1988 | 680 | 0.020 |
Why?
|
| Macrophages | 1 | 1979 | 5655 | 0.010 |
Why?
|
| Aged | 7 | 1996 | 162944 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1849 | 0.010 |
Why?
|
| Quantum Theory | 1 | 1983 | 70 | 0.010 |
Why?
|
| Ouabain | 1 | 1983 | 264 | 0.010 |
Why?
|
| Protein Transport | 1 | 2008 | 1988 | 0.010 |
Why?
|
| Deoxyuridine | 1 | 1982 | 33 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1998 | 4029 | 0.010 |
Why?
|
| Clinical Medicine | 1 | 2003 | 147 | 0.010 |
Why?
|
| Biological Transport | 1 | 1987 | 2119 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1990 | 1806 | 0.010 |
Why?
|
| Italy | 1 | 2003 | 828 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1990 | 1887 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1984 | 1144 | 0.010 |
Why?
|
| San Francisco | 1 | 2000 | 159 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 1980 | 258 | 0.010 |
Why?
|
| Schistosoma japonicum | 1 | 1979 | 5 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1990 | 3760 | 0.010 |
Why?
|
| Benzoyl Peroxide | 1 | 1998 | 14 | 0.010 |
Why?
|
| Lymphoma | 1 | 1988 | 1873 | 0.010 |
Why?
|
| Opsonin Proteins | 1 | 1979 | 150 | 0.010 |
Why?
|
| Benzene Derivatives | 1 | 1998 | 54 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 3910 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2008 | 2410 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1991 | 10248 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2000 | 571 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1993 | 2645 | 0.010 |
Why?
|
| Methionine | 1 | 1980 | 590 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 2000 | 642 | 0.010 |
Why?
|
| Diffusion | 1 | 1979 | 832 | 0.010 |
Why?
|
| Phycoerythrin | 1 | 1997 | 8 | 0.010 |
Why?
|
| Amidines | 1 | 1997 | 30 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 19862 | 0.010 |
Why?
|
| Temperature | 1 | 1983 | 2207 | 0.010 |
Why?
|
| Health Care Rationing | 1 | 2000 | 435 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1977 | 3744 | 0.010 |
Why?
|
| Myocardium | 1 | 1990 | 4775 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1978 | 664 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1996 | 156 | 0.010 |
Why?
|
| Singlet Oxygen | 1 | 1996 | 53 | 0.010 |
Why?
|
| Artiodactyla | 1 | 1976 | 2 | 0.010 |
Why?
|
| Fluorescein | 1 | 1997 | 169 | 0.010 |
Why?
|
| Snakes | 1 | 1976 | 30 | 0.010 |
Why?
|
| Adult | 6 | 2008 | 213712 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1978 | 841 | 0.010 |
Why?
|
| Software | 1 | 1990 | 4434 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1998 | 2452 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1976 | 277 | 0.010 |
Why?
|
| Venoms | 1 | 1976 | 91 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1976 | 356 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2000 | 694 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1983 | 2013 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1976 | 1386 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1456 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 5163 | 0.010 |
Why?
|
| Calcium | 1 | 1987 | 5753 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1995 | 380 | 0.010 |
Why?
|
| Sheep | 1 | 1976 | 1437 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1979 | 3139 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1993 | 365 | 0.010 |
Why?
|
| Brain | 1 | 1998 | 26343 | 0.010 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1990 | 68 | 0.010 |
Why?
|
| Ligation | 1 | 1991 | 453 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 9185 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1990 | 290 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1989 | 163 | 0.010 |
Why?
|
| Bismuth | 1 | 1988 | 29 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 1990 | 247 | 0.010 |
Why?
|
| Dithioerythritol | 1 | 1987 | 8 | 0.000 |
Why?
|
| Acetic Acid | 1 | 1987 | 55 | 0.000 |
Why?
|
| Neutrophils | 1 | 1979 | 3711 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1991 | 843 | 0.000 |
Why?
|
| Platelet Count | 1 | 1989 | 780 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1991 | 57683 | 0.000 |
Why?
|
| Mutation | 1 | 1990 | 29717 | 0.000 |
Why?
|
| Acetates | 1 | 1987 | 312 | 0.000 |
Why?
|
| Oxygen | 1 | 1996 | 4169 | 0.000 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1986 | 349 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1986 | 637 | 0.000 |
Why?
|
| Papio | 1 | 1986 | 656 | 0.000 |
Why?
|
| Carcinoma, Papillary | 1 | 1989 | 781 | 0.000 |
Why?
|
| Risk Factors | 1 | 1990 | 72145 | 0.000 |
Why?
|
| Medicare | 1 | 2000 | 6532 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1984 | 11690 | 0.000 |
Why?
|
| Endometriosis | 1 | 1989 | 834 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1987 | 4013 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1986 | 4839 | 0.000 |
Why?
|